US 11219604
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
granted A61KA61K31/56A61K31/58
Quick answer
US patent 11219604 (Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith) held by Eupraxia Pharmaceuticals USA LLC expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Eupraxia Pharmaceuticals USA LLC
- Grant date
- Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/56, A61K31/58, A61K9/0024, A61K9/5026